Omer Raheem to Protein Kinase Inhibitors
This is a "connection" page, showing publications Omer Raheem has written about Protein Kinase Inhibitors.
Connection Strength
0.020
-
Does timing of cytoreductive nephrectomy impact patient survival with metastatic renal cell carcinoma in the tyrosine kinase inhibitor era? A multi-institutional study. Urology. 2013 Apr; 81(4):805-11.
Score: 0.020